
NEW YORK, March 10, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

Company Announcement Genmab gains exclusive access to multiple novel proprietary tumor targets identified by ...
Click to continue to site. Closing